Skip to content

Evolus EOLS Operating margin

Operating margin at other companies

AbbVie logo
AbbVieABBV
24.4%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

Based on trailing twelve months.

The official record: Evolus’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Evolus's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's operating margin?
Evolus (EOLS) reported operating margin of -13.7% in Q3 2025.
How has Evolus's operating margin changed year-over-year?
Evolus's operating margin increased by 16.4% year-over-year, from -16.4% to -13.7%.
What is the long-term trend for Evolus's operating margin?
Over 4 years (2020 to 2024), Evolus's operating margin has grown at a -53.3% compound annual growth rate (CAGR), from -270.7% to -12.9%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.